Lung Cancer Clinical Trial

Physical Activity Intervention for Lung Cancer Survivors

Summary

The purpose of this study is to learn how many lung cancer survivors will agree to a physical activity program. We also want to know if lung cancer survivors benefit from this program. This information will help us to develop our services for lung cancer survivors.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis and treatment at MSKCC of primary NSCLC; and/or pulmonary carcinoid;
At least one year post thoracic surgical resection;
Have no evidence of NSCLC or any other cancer at the time of study enrollment and not receiving any cancer treatment;
Currently sedentary or insufficiently active, defined by the American College of Sports Medicine (ACSM) and the Centers for Disease Control and Prevention as less than a total of 150 minutes of at least moderate intensity PA per week;
Able to complete a six-minute walk test (6MWT);
Able to provide informed consent.

FOCUS GROUP ONLY:

• Completed the Physical Activity program offered through this study (08067);

Exclusion Criteria:

Presence of one of the following medical factors at screening:

regular use of an ambulatory aid (cane or walker);
resting oxygen saturation less than 88%;
inability to walk due to severe arthritis or other musculoskeletal problems;
a diagnosis of unstable angina in the previous 6 weeks;
a heart attack, angioplasty or heart surgery in the previous 3 months;
current heart rate <50 or >120 at rest; current uncontrolled hypertension;
current significant valvular heart disease or decompensated congestive heart failure and
patient reported pain of any origin that would preclude participation in the proposed PA intervention
Evidence of significant medical cognitive or psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in the intervention
Self-reporting of greater than 60 minutes of vigorous activity per week or 150 minutes of moderate intensity PA per week.
Patient resides at more than two hours travel distance from the Center
Insufficient English fluency to complete evaluation tools.

Study is for people with:

Lung Cancer

Estimated Enrollment:

52

Study ID:

NCT00717795

Recruitment Status:

Completed

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

52

Study ID:

NCT00717795

Recruitment Status:

Completed

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.